Navigation Links
Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
Date:5/21/2008

netic discrimination was only prohibited under loose state and federal regulations, causing consumers to be wary of taking genetic tests or participating in genetic research studies for fear that negative results could be used against them by insurers or employers. With the signing of GINA, consumers should be more willing to have genetic testing that can determine their predisposition to specific diseases; thereby allowing the individual to make lifestyle changes and/or take preventive measures to avoid disease.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin is headquartered in Waltham, MA. For more information about Interleukin, its products and ongoing programs, please visit http://www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements including statements regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations, our ability to screen nutritional compounds for their effects on inflammatory responses and other genetic variations, given specific genetic patterns and our ability to make progress in advancing our core technologies. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implie
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
5. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
8. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
9. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
10. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4Superior offspring without genetic modification 2Researchers finds hidden sensory system in the skin 2Researchers finds hidden sensory system in the skin 3Pelosi 3A Health Insurance Reform Essential for Women 59017 1Pelosi 3A Health Insurance Reform Essential for Women 59017 2Pelosi 3A Health Insurance Reform Essential for Women 59017 3Pelosi 3A Health Insurance Reform Essential for Women 59017 4Pelosi 3A Health Insurance Reform Essential for Women 59017 5American Heart Association Quality News 3A Commitment to Quality Results in Lower Mortality Rates for Heart Attack and Heart Failure Patients 59012 1American Heart Association Quality News 3A Commitment to Quality Results in Lower Mortality Rates for Heart Attack and Heart Failure Patients 59012 2American Heart Association Quality News 3A Commitment to Quality Results in Lower Mortality Rates for Heart Attack and Heart Failure Patients 59012 3Unomedical Issues Worldwide Recall of Certain Manual Pulmonary Resuscitators 5279 1Unomedical Issues Worldwide Recall of Certain Manual Pulmonary Resuscitators 5279 2